CClinicalTrials.gg
CompletedNCT04414527MCHUpdated Dec 6, 2021

Effects of Video-based Health Education on Maternal and Child Health in Ethiopia

An interventional study of Standard counselling and Health-Video in Anemia, Antenatal Care and Birth Outcomes, sponsored by University Ghent. Completed at 1 site in Ethiopia. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-12-06.

Sponsored by University Ghent · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
675
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Low adherence to recommended health and nutrition strategies during the critical 1000 day-window of opportunity is multifactorial but low quality communication is key limitation. Innovative strategies to improve interpersonal communication can reduce the burden and the fatigue of community health workers and may result in a greater change. The findings of this project will support governments and other stakeholders in their delivery of high impact nutrition and health practices.

This intervention aims to improve adherence to ante- and post-natal care practices and recommendations by the use of our video-based health education. These videos will be implemented through home-based counseling by trained assistants, and video-based forum participation led by community nurses and health extension workers (HEWs). During the monthly forums, the educational package will be delivered in a video form - locally prepared using multiple approaches like testimony, comedy, dramas in the form of questions and answers, group discussions and deductive approaches. Cordless projectors and locally created videos give the health community more quality control over the end message, expand the number of people reached, allow for the use of minimally trained non-expert facilitators such as the hews, and allow for contextually appropriate information. They can also be used in areas without access to electricity, helping to bridge the digital divide, and serving as a leapfrog technology for areas that would otherwise not have access to media.

Read the detailed description

In Ante- and post-natal care, low adherence to recommended health and nutrition strategies during the critical 1,000 day-window of opportunity is multifactorial, but low-quality communication is key limitation. Innovative strategies to improve interpersonal communication can reduce the burden and the fatigue of community health workers and may result in a greater change. The findings of this project will support governments and other stakeholders in their delivery of high impact nutrition and health practices.

Focused antenatal care (FANC), including iron and folic acid supplementation (IFA) is one of the main strategies to reduce maternal and child deaths. The WHO recommends at least four hospital visits during the pregnancy. Supplementation with IFA during pregnancy improves birth weight and reduces megaloblastic anemia by 79%. The uptake of nutritional and health practices is influenced by complex, contextual determinants at the individual and community levels. Evidence showed that Social and Behavior Change Communication (SBCC) is an effective approach to increase the uptake of key strategies and to sustain behavior change.

Ethiopia, a low-income country in sub-Saharan Africa, has one of the highest maternal and infant mortality rates. It is estimated that 676 mothers die per 100,000 live births and that 59 infants die per 1,000 live births. Maternal anemia is associated with an increased risk of maternal death. Iron deficiency anemia is a strong risk factor for low birthweight (LBW) and perinatal mortality. genital infections such as bacterial vaginosis, candidiasis and worm infections (such as intestinal hookworm infections) are considered important infections that possibly could confound the study results. Bacterial vaginosis and candidiasis are a known risk factor for preterm birth. these infections are also linked with anemia and maternal nutritional status. Hookworm infections are highly prevalent in Ethiopia and are associated with undernutrition and anemia.

The reports of the Ethiopian Demographic and Health Survey showed an increase in women aged 15-49 years in Ethiopia receiving antenatal care (ANC) from a skilled provider up to 62% in 2016 (EDHS, 2016). The percentage of women taking IFA supplements for 90 days or more remains at a substandard level of only 5% (EDHS, 2016). Antenatal care coverage for at least one visit is 28% but coverage for at least four visits declines to 12%, suggesting systemic barriers that potentially prevent the mothers from returning to the health centers. One of the barriers may be perceived failure of the existing interventions to make a meaningful impact that could stimulate the desired behavioral change.

This intervention aims to improve adherence to ante- and post-natal care practices and recommendations by the use of our video-based health education. These videos will be implemented through home-based counseling by trained assistants, and video-based forum participation led by community nurses and Health Extension Workers (HEWs). The nutrition-specific education packages will be based on the WHO-UNICEF key messages booklet on the community, infant and young child feeding counseling package and will be culturally adjusted to fit the local context and translated into the main four local languages. The videos will also include some hygienic aspects that reduce the risk of both genital and parasitic infections, that are also causing undernutrition, anemia and/or adverse pregnancy outcomes. During the monthly forums, the educational package will be delivered in a video form - locally prepared using multiple approaches like testimony, comedy, dramas in the form of questions and answers, group discussions and deductive approaches (more details can be found on OMPT website https://www.ompt.org/).

The main objective of this project is to assess the effects of this innovative video-based health education on reproductive health, and on birth outcomes and the nutritional status of women and their infants from birth to six months of age.

PRIMARY OBJECTIVES

  1. To assess the effects of video-based health education package provided to pregnant and lactating women on the knowledge, attitude and practice on recommended health including adherence to ANC visits and to IFA supplementation.
  2. To assess the effects of video-based health education on birth outcomes and anemia status of women during pregnancy, at delivery and six-month postpartum.
  3. To evaluate the effect of video-based health education on early initiation and exclusive breastfeeding (EBF) of infants from 0-6 months of age In this two-arm cluster randomized trial, 675 pregnant women in their first trimester (12 weeks of gestation) will be recruited and followed up until delivery and then with their infants for six months postpartum.

The intervention will include home to home visit for delivery of healthy nutrition and hygienic messages using prepared video-based messages. participation in monthly forums will be facilitated by nurses using also videos for demonstration of nutritional and hygienic care and will be delivered at the homes of the participants every month by trained HEW until delivery, in addition to the ANC regular visits. During the monthly forums (six in total during the pregnancy and the post-partum periods), the messages will all be given as a video show, coordinated by a nurse/ health professional who will further answer any questions. During the postnatal period, two counseling sessions will be organized within the first two weeks after birth, and a further six sessions ( every month) till 6 months postnatally.

The HEW will distribute the IFA 30 tablets (30 mg elemental iron and 400 µg of folic acid) every month, and will provide counseling on the importance of- and instructions on adherence and other recommendations as detailed earlier. Pregnant women in the control group will receive the standard education package as per the Ethiopian guidelines. In the standard health care, pregnant women receive a minimum of four ANC visits at the health centers during which they also receive IFA supplementation. The control and the intervention groups receive the same amount of tablets (i.e. 30 tablets containing 30 mg elemental iron and 400 µg of folic acid, every month). Monthly IFA utilization will be checked through HEW or our trained service delivery workers during home to home visit. Women who test positive for soil-transmitted helminth will be treated according to the national protocol starting from the second trimester (treatment is not advised during the first trimester). Women who experience odor, itching or discharge will be treated for candidiasis and bacterial vaginosis.

Data will be collected in pregnant women at baseline, at six and at 9 months of pregnancy . After delivery data will be collected in the pairs mother-infant within two weeks and at 3 and 6 months postpartum. At the different time points, biological samples will be collected to assess the micronutrient status, the presence of inflammations and the presence of genital and parasitic infections.

02

Conditions studied

  • Anemia
  • Antenatal Care
  • Birth Outcomes
  • Worm Infection
  • Bacterial Vaginoses
  • Exclusive Breastfeeding

Keywords

  • Video-based behavior change communication
  • Iron and folic acid supplementation
  • Antenatal care
  • Soil transmitted helminths
  • Bacterial vaginoses
  • Exclusive breastfeeding
03

In context

Vaginosis, Bacterial

220 studies on the registry are indexed under Vaginosis, Bacterial; 36 are open to participants now.

This study's enrollment of 675 is above the median of 100 across 187 interventional studies indexed under Vaginosis, Bacterial.

Browse Vaginosis, Bacterial studies →

Lead sponsor

University Ghent is the lead sponsor of 345 studies on the registry; 85 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Signed informed consent form
  • Aged at least 18 years
  • Permanent resident of the village of the study intervention/control
  • Planned availability during the whole period of the study (12 months)
  • Acceptance of the intervention package including home visits for data collection and morbidity follow up.

Exclusion criteria

Exclusion Criteria:

  • Severe anemia (hemoglobin \<70 g/L),
  • Under nutrition (defined as body mass index before pregnancy of \<18.5 kg/m2),
  • Chronically ill mothers with tuberculosis or other chronic diseases,
  • Reported HIV-positive mother.
  • Individuals with anatomical deformity will be excluded due to the difficulty of measurement of height.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
675 participants (actual)

Study arms

  • Other
    Standard counseling

    Pregnant women in the control group will receive the standard education package as per the Ethiopian guidelines. In the standard health care, pregnant women receive a minimum of four ante-natal care visits at the health centers during which they also receive iron and folic acid supplementation. They participate in monthly forums facilitated by nurses to answer questions and concerns regarding nutritional care.

    Behavioral: Standard counselling

  • Experimental
    Health-Video

    Women in the Health-Video group will receive home visits for delivery of healthy nutrition messages using prepared video-based messages every two weeks. They will also participate in monthly forums facilitated by nurses using also videos for demonstration of nutritional care. During the monthly forums (six in total during the pregnancy and the post-partum periods), the messages will all be given as a video show coordinated by a nurse/ health professional for any questions. During postnatal period, two counseling sessions will be delivered within two weeks of birth, and 12 sessions or twice every month till 6 months.

    Behavioral: Health-Video

Interventions

  • BehavioralStandard counselling

    The control cohort will receive national standard counseling during four ante-natal care visits. Women in the control group will receive additionally 1. national nutrition and health care including IFA supplementation, 2. treatment of any symptomatic health condition and deworming in case of symptomatic complaints during second and third trimesters, 3. Women who experience odor, itching or discharge will be treated for candidiasis and bacterial vaginosis.

    Also known as: Control

  • BehavioralHealth-Video

    The intervention cohort Health-Video will receive innovative video-based nutritional and hygienic education. Women in this group will receive additionally: 1. National nutrition and health care including IFA supplementation 2. treatment of any symptomatic health condition and deworming in case of symptomatic complaints during second and third trimesters, 3. Women who experience odor, itching or discharge will be treated for candidiasis and bacterial vaginosis.

    Also known as: Video-based counselling

06

What researchers measure

Primary outcomes

  1. Adherence to iron and folic acid supplementation during pregnancy

    Monthly disappearance rate of IFA tablets

    Time frame: Monthly during six months pregnancy

  2. Adherence to iron and folic acid supplementation post-partum

    Monthly disappearance rate of IFA tablets

    Time frame: Monthly during three months postpartum

  3. Maternal anemia during pregnancy

    Hemoglobin concentrations (g/dL)

    Time frame: Hemoglobin concentrations will be measured at 9 months pregnancy

  4. Maternal anemia post-partum

    Hemoglobin concentrations (g/dL)

    Time frame: Hemoglobin concentrations will be measured at six months postpartum

  5. Early initiation

    Prevalence of newborns put to the breast in the first hour after birth

    Time frame: At birth (six months after the enrollment)

  6. Exclusive breastfeeding

    Prevalence of infants exclusively breastfed using maternal reports and the deuterium dose-to-mother technique (in a subgroup)

    Time frame: Birth to six months postpartum

  7. Dietary intake during six months pregnancy

    Prevalence of women with adequate dietary intake during six months pregnancy

    Time frame: Assessed at 6 months and 9 months pregnancy

  8. Dietary intake at six months post-partum

    Prevalence of women with adequate dietary intake at six months post-partum

    Time frame: Assessed at six months postpartum

Secondary outcomes

  1. Gestational weight gain

    Weight gain at term (Kg)

    Time frame: Gestational weight gain will be measured in all pregnant women at six and nine months pregnancy

  2. Maternal genital infections

    The presence of genital infections that are known to affect a healthy pregnancy, including but not limited to bacterial vaginosis, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Listeria monocytogenes.

    Time frame: Maternal genital infections will be assessed at nine months pregnancy

  3. Birth weight

    Birth weight (g)

    Time frame: Birth weight will be assessed in all newborns

  4. Infant weight

    Infant weight (g) on a monthly basis

    Time frame: Weight of infants will be assessed monthly from birth until six months of age

  5. Infant length

    Infant length (cm) on a monthly basis

    Time frame: Length of infants will be assessed monthly from birth until six months of age

  6. Infant anemia

    Hemoglobin concentrations (g/dL)

    Time frame: Hemoglobin concentrations will be measured at six months of age

  7. Maternal parasitic infections

    The presence of worm parasites and egg density in the stools. Three common parasites and their eggs will be investigated, i.e. Ascaris lumbricoides (round worm), Trichuris trichiura (whipworm) and Ancyclostoma duodenale or Necater americanus (hookworms).

    Time frame: Worm infections will be assessed in all women at 6 months pregnancy, 9 months pregnancy, and at two weeks- and 6 months post partum

  8. Infant parasitic infections

    The prevalence of Giarida and Cryposporidium will be assessed in all infants

    Time frame: Infant parasitic infections will be assessed at 6 months of age.

  9. Maternal plasma ferritin

    Iron status as indicated plasma ferritin (micro_g/L) is a test to evaluate iron stores

    Time frame: Plasma ferritin is assessed in a subgroup of women at 9 months pregnancy and at six months postpartum

  10. Infant plasma ferritin

    Iron status as indicated plasma ferritin (micro_g/L) is a test to evaluate iron stores

    Time frame: Plasma ferritin is assessed in a subgroup of infants at six months of age

  11. Maternal soluble transferrin receptor

    Soluble transferrin receptor (mg/L) is an indicator for iron deficiency especially in high inflammation settings

    Time frame: Plasma ferritin is assessed in a subgroup of women at 9 months pregnancy and at six months postpartum

  12. Infant soluble transferrin receptor

    Soluble transferrin receptor (mg/L) is an indicator for iron deficiency especially in high inflammation settings

    Time frame: Soluble transferrin receptor is assessed in a subgroup of infants at six months of age

  13. Maternal serum concentrations in Vitamin A (retinol)

    Retinol concentrations in serum is an indicator of vitamin A status

    Time frame: Serum concentrations in Vitamin A are assessed in a subgroup of women at 9 months pregnancy and at six months postpartum

  14. Infant serum concentrations in Vitamin A (retinol)

    Retinol concentrations in serum is an indicator of vitamin A status

    Time frame: Serum concentrations in Vitamin A are assessed in a subgroup of infants at six months of age

  15. Maternal serum concentrations in vitamin B12

    Serum concentrations in vitamin B12

    Time frame: Vitamin B12 concentrations will be assessed in a subgroup of women at 9 months pregnancy and at six months postpartum

  16. Infant serum concentrations in vitamin B12

    Serum concentrations in vitamin B12

    Time frame: Vitamin B12 concentrations will be assessed in a subgroup of infants at six months of age

07

Study locations

1 site
  • Arba Minch University
    Arba Minch, Dirashe District, Ethiopia
08

References and documents

Publications

  • Lassi ZS, Salam RA, Haider BA, Bhutta ZA. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD006896. doi: 10.1002/14651858.CD006896.pub2. PubMed 23543547 ↗
  • Rasmussen KM, Stoltzfus RJ. New evidence that iron supplementation during pregnancy improves birth weight: new scientific questions. Am J Clin Nutr. 2003 Oct;78(4):673-4. doi: 10.1093/ajcn/78.4.673. No abstract available. PubMed 14522723 ↗
  • Brooker S, Bethony J, Hotez PJ. Human hookworm infection in the 21st century. Adv Parasitol. 2004;58:197-288. doi: 10.1016/S0065-308X(04)58004-1. PubMed 15603764 ↗
  • Prociv P, Luke RA. Evidence for larval hypobiosis in Australian strains of Ancylostoma duodenale. Trans R Soc Trop Med Hyg. 1995 Jul-Aug;89(4):379. doi: 10.1016/0035-9203(95)90016-0. No abstract available. PubMed 7570868 ↗
  • Asundep NN, Jolly PE, Carson AP, Turpin CA, Zhang K, Wilson NO, Stiles JK, Tameru B. Effect of Malaria and Geohelminth Infection on Birth Outcomes in Kumasi, Ghana. Int J Trop Dis Health. 2014;4(5):582-594. doi: 10.9734/IJTDH/2014/7573. PubMed 25414840 ↗
  • Kavle JA, Landry M. Addressing barriers to maternal nutrition in low- and middle-income countries: A review of the evidence and programme implications. Matern Child Nutr. 2018 Jan;14(1):e12508. doi: 10.1111/mcn.12508. Epub 2017 Aug 24. PubMed 28836343 ↗
  • Verstraelen H, Delanghe J, Roelens K, Blot S, Claeys G, Temmerman M. Subclinical iron deficiency is a strong predictor of bacterial vaginosis in early pregnancy. BMC Infect Dis. 2005 Jul 6;5:55. doi: 10.1186/1471-2334-5-55. PubMed 16000177 ↗
  • Tuddenham S, Ghanem KG, Caulfield LE, Rovner AJ, Robinson C, Shivakoti R, Miller R, Burke A, Murphy C, Ravel J, Brotman RM. Associations between dietary micronutrient intake and molecular-Bacterial Vaginosis. Reprod Health. 2019 Oct 22;16(1):151. doi: 10.1186/s12978-019-0814-6. PubMed 31640725 ↗
  • Ashorn P, Hallamaa L, Allen LH, Ashorn U, Chandrasiri U, Deitchler M, Doyle R, Harjunmaa U, Jorgensen JM, Kamiza S, Klein N, Maleta K, Nkhoma M, Oaks BM, Poelman B, Rogerson SJ, Stewart CP, Zeilani M, Dewey KG. Co-causation of reduced newborn size by maternal undernutrition, infections, and inflammation. Matern Child Nutr. 2018 Jul;14(3):e12585. doi: 10.1111/mcn.12585. Epub 2018 Jan 8. PubMed 29316198 ↗
  • Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, Webb P, Lartey A, Black RE; Lancet Nutrition Interventions Review Group, the Maternal and Child Nutrition Study Group. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet. 2013 Aug 3;382(9890):452-477. doi: 10.1016/S0140-6736(13)60996-4. Epub 2013 Jun 6. Erratum In: Lancet. 2013 Aug 3;382(9890):396. PubMed 23746776 ↗

Individual participant data

Plan to share: No — All the data that can affect the main or the secondary outcomes will be used in the analyses and shared as necessary. Data on helminthic infection will use household characteristics and women and infants nutritional status

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04414527
Lead sponsor
University Ghent
Collaborators
Flemish Interuniversity Council (VLIR), Arba Minch University
Responsible party
Sponsor
First posted
Jun 4, 2020
Start date
Mar 13, 2020
Primary completion
Jul 31, 2021
Completion
Jul 31, 2021
Last update
Dec 6, 2021

Study contacts

Stefaan De Henauw, Md. PhD
principal investigator · University Ghent
Souheila Abbeddou, MSc. PhD
principal investigator · University Ghent
Bruno Levecke, PhD
principal investigator · University Ghent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion